CONTEXT THERAPEUTICS INC (CNTX) — insider trading
Health Care · NASDAQ
CONTEXT THERAPEUTICS INC (CNTX) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-06-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | Kantoff Philip W. | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Walker Luke Nathaniel | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Smith Karen L. | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-24 | West Linda | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Stacey Jennifer Evans | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Pasternak Andy | Director | Grant / award / vesting (derivative) | 45,000 | $0.00 | $0 | Form 4 |
| 2026-02-19 | Lehr Martin A. | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 815,000 | $0.00 | $0 | Form 4 |
| 2026-02-19 | Chagin Karen Deborah | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 290,000 | $0.00 | $0 | Form 4 |
| 2026-02-19 | Minai-Azary Jennifer Lynn | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 275,000 | $0.00 | $0 | Form 4 |
| 2026-02-19 | Levit Alex C. | Officer (Chief Legal Officer, Corp. Sec) | Grant / award / vesting (derivative) | 270,000 | $0.00 | $0 | Form 4 |
| 2025-06-12 | Kantoff Philip W. | Director | Grant / award / vesting (derivative) | 123,500 | $0.00 | $0 | Form 4 |
| 2025-06-12 | Pasternak Andy | Director | Grant / award / vesting (derivative) | 138,900 | $0.00 | $0 | Form 4 |
Ask the chat about CNTX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CONTEXT THERAPEUTICS INC (CNTX).
Last updated 2026-06-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.